Related Experiment Video
Updated: Jan 9, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Is the superior septal approach a safe alternative to conventional left atriotomy for mitral valve surgery? Evidence
Alaa Maali1, Harald Hausmann1, Robert Flieger1
1Evangelisches Herzzentrum Coswig, Lerchefeld 1, 06869, Coswig, Germany.
Abstract:
BACKGROUND: The superior septal approach (SSA) was developed to improve mitral valve exposure during surgery, particularly in patients with complex anatomy. However, concerns regarding prolonged operative times and rhythm disturbances have limited its widespread adoption. This systematic review and meta-analysis aimed to compare SSA with conventional left atriotomy (CLA) in terms of perioperative outcomes, complications, rhythm disturbances, and mortality. METHODS: A systematic search of PubMed, Scopus, and Web of Science was performed up to August 2025 according to PRISMA guidelines. Outcomes assessed included postoperative cardiac rhythm outcomes (primary outcomes), perioperative metrics (secondary outcomes) -including pacemaker implantation, cardiopulmonary bypass (CPB) and cross-clamp times, intensive care unit (ICU) stay, and hospital stay, and complications (safety outcomes). Pooled risk ratios (RR) and mean differences (MD) with 95% confidence intervals (CI) were calculated using a random-effects model. RESULTS: A total of 12 cohort studies were included. Postoperative sinus rhythm (RR = 0.86, 95% CI 0.71–1.04) and atrial fibrillation (AF) (RR = 1.12, 95% CI 0.83–1.49) did not differ between SSA and CLA; junctional rhythm and complete atrioventricular block (AVB) were also comparable. Within-group (pre–post) analyses showed sinus rhythm increased after both techniques, more with SSA (RR = 1.36) than CLA (RR = 1.20), while AF changes were non-significant. Meta-regression indicated more recent publication year and higher repair (vs. replacement) proportion were associated with greater sinus rhythm benefit favoring SSA. Secondary outcomes were similar overall; pacemaker implantation was borderline higher after SSA and became significant in sensitivity analysis. Safety endpoints were also comparable between approaches. CONCLUSION: The SSA provides equivalent perioperative efficiency and clinical safety compared with CLA in mitral valve surgery. Concerns about rhythm disturbances and operative burden are not supported by pooled evidence, suggesting that SSA remains a safe and valuable option, particularly in cases requiring enhanced exposure. Further high-quality prospective studies are warranted to define long-term outcomes and refine patient selection.
Related Concept Videos
Mitral Stenosis III: Medical Management
Mitral Stenosis I: Introduction
Mitral Regurgitation III: Medical Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation I: Introduction

